PlGF in a clinical setting of pregnancies at risk of preeclampsia and/or intrauterine growth restriction

Journal of Maternal-Fetal and Neonatal Medicine

Volumn 30, Issue 2, 2017, Pages 144-149

  Cetin, Irene ^a,b   Mazzocco, Martina I ^a,b   Giardini, Valentina ^c   Cardellicchio, Manuela ^a,b   Calabrese, Stefania ^a,b   Algeri, Paola ^c   Martinelli, Anna ^a,b   Todyrenchuk, Lyudmyla ^c   Vergani, Patrizia ^c  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

IUGR; preeclampsia; pregnancy outcomes; uterine artery Doppler velocimetry

Indexed keywords

PLACENTAL GROWTH FACTOR; BIOLOGICAL MARKER;

ADULT; ARTICLE; BIRTH WEIGHT; CESAREAN SECTION; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER FLOWMETRY; FEMALE; GESTATIONAL AGE; HUMAN; IMMUNOASSAY ANALYZER; INTRAUTERINE GROWTH RETARDATION; PREECLAMPSIA; PREGNANCY OUTCOME; PRIORITY JOURNAL; PULSATILITY INDEX; SENSITIVITY AND SPECIFICITY; UTERINE ARTERY; BLOOD; CHI SQUARE DISTRIBUTION; DIAGNOSTIC IMAGING; FETAL GROWTH RETARDATION; LASER DOPPLER FLOWMETRY; METABOLISM; PLACENTA; PLASMA; PRE-ECLAMPSIA; PREGNANCY; PROSPECTIVE STUDY; RISK FACTOR;

ADULT; BIOMARKERS; CHI-SQUARE DISTRIBUTION; FEMALE; FETAL GROWTH RETARDATION; GESTATIONAL AGE; HUMANS; LASER-DOPPLER FLOWMETRY; PLACENTA; PLACENTA GROWTH FACTOR; PLASMA; PRE-ECLAMPSIA; PREGNANCY; PROSPECTIVE STUDIES; RISK FACTORS; UTERINE ARTERY;

EID: 84964325452     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2016.1168800     Document Type: Article

References (23)

1. Luo ZC, An N, Xu HR, et al. The effects and mechanisms of primiparity on the risk of pre-eclampsia:a systematic review. Paediatr Perinat Epidemiol 2007;21:36–45
2. Duckitt K, Harrington D., Risk factors for pre-eclampsia at antenatal booking:systematic review of controlled studies. BMJ 2005;330:565
3. Gómez O, Figueras F, Martínez JM, et al. Sequential changes in uterine artery blood flow pattern between the first and second trimesters of gestation in relation to pregnancy outcome. Ultrasound Obstet Gynecol 2006;28:802–8
4. Cetin I, Huppertz B, Burton G, et al. Pregenesys pre-eclampsia markers consensus meeting:what do we require from markers, risk assessment and model systems to tailor preventive strategies? Placenta 2011;32:S4eS16
5. Levine RJ, Maynard SE, Qian C, et al. Circulating angiogenic factors and the risk of preeclampsia. N Engl J Med 2004;350:672–83
6. Rana S, Powe CE, Salahuddin S, et al. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation 2012;125:911–9
7. Sibiude J, Guibourdenche J, Dionne MD, et al. Placental growth factor for the prediction of adverse outcomes in patients with suspected preeclampsia or intrauterine growth restriction. PLoS One 2012;7:e50208
8. Chappell LC, Duckworth S, Seed PT, et al. Diagnostic accuracy of placental growth factor in women with suspected preeclampsia:a prospective multicenter study. Circulation 2013;128:2121–31
9. Sibai BM., Diagnosis and management of gestational hypertension and preeclampsia. Obstet Gynecol 2003;102:181–92
10. Todros T, Ferrazzi E, Groli C, et al. Fitting growth curves to head and abdomen measurements of the fetus:a multicentric study. J Clin Ultrasound 1987;15:95–105
11. Di Battista E, Bertino E, Benso L, et al. Longitudinal distance standards of fetal growth. Intrauterine and Infant Longitudinal Growth Study:IILGS. Acta Obstet Gynecol Scand 2000;79:165–73
12. Brown MA, Lindheimer MD, de Swiet M, et al. The classification and diagnosis of the hypertensive disorders of pregnancy:statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001;20:IX–XIV
13. Plasencia W, Maiz N, Poon L, et al. Uterine artery Doppler at 11 + 0 to 13 + 6 weeks and 21 + 0 to 24 + 6 weeks in the prediction of pre-eclampsia. Ultrasound Obstet Gynecol 2008;32:138–46
14. Pardi G, Cetin I, Marconi AM, et al. Diagnostic value of blood sampling in fetuses with growth retardation. N Engl J Med 1993;328:692–6
15. Molvarec A, Gullai N, Stenczer B, et al. Comparison of placental growth factor and fetal flow Doppler ultrasonography to identify fetal adverse outcomes in women with hypertensive disorders of pregnancy:an observational study. BMC Pregnancy Childbirth 2013;13:161
16. Cetin I, Alvino G., Intrauterine growth restriction:implications for placental metabolism and transport. A review. Placenta 2009;30:77–82
17. Mandò C, De Palma C, Stampalija T, et al. Placental mitochondrial content and function in intrauterine growth restriction and preeclampsia. Am J Physiol Endocrinol Metab 2014;306:E404–13
18. Benton SJ, Hu Y, Xie F, et al. Can placental growth factor in maternal circulation identify fetuses with placental intrauterine growth restriction? Am J Obstet Gynecol 2012;206:163.e1–7
19. Lobmaier SM, Figueras F, Mercade I, et al. Angiogenic factors versus Doppler follow up in the prediction of adverse outcome among late pregnancy small-for-gestational-age fetuses. Ultrasound Obstet Gynecol 2014;43:533–40
20. Redman CW, Sargent IL, Staff AC., IFPA Senior Award Lecture:making sense of pre-eclampsia–two placental causes of preeclampsia? Placenta 2014;35(Suppl):S20–5
21. Espinoza J, Romero R, Nien JK, et al. Identification of patients at risk for early onset and/or severe preeclampsia with the use of uterine artery Doppler velocimetry and placental growth factor. Am J Obstet Gynecol 2007;196:326.e1–13
22. Stepan H, Unversucht A, Wessel N, Faber R., Predictive value of maternal angiogenic factors in second trimester pregnancies with abnormal uterine perfusion. Hypertension 2007;49:818–24
23. Crispi F, Llurba E, Dominguez C, et al. Predictive value of angiogenic factors and uterine artery Doppler for early- versus late-onset pre-eclampsia and intrauterine growth restriction. Ultrasound Obstet Gynecol 2008;31:303–9